Who
William K. McVicar
Director
Company insider
Files Form 4 as: President and CEO, Decoy Therapeutics; Officer, Rocket Pharmaceuticals.
In numbers
- Trades disclosed
- 17
- Buys
- 2
- Sells
- 0
- Bought
- $15K
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 24 Jun 2015
- Last trade
- 31 Aug 2026
- Last filed
- 2 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 31 Aug 2026filed 2 Sep 2026 | DCOY Decoy TherapeuticsBiotechnology | SEC FORM 4 Code A | —3,000 at $0.00 | filing |
| 31 Aug 2026filed 2 Sep 2026 | DCOY Decoy TherapeuticsBiotechnology | SEC FORM 4 Code A | —3,000 at $0.00 | filing |
| 20 Feb 2024filed 22 Feb 2024 | DCOY Decoy Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,500 at $0.00 | filing |
| 3 Jan 2023filed 5 Jan 2023 | DCOY Decoy TherapeuticsBiotechnology | SEC FORM 4 Code A | —1,440 at $0.00 | filing |
| 6 Jun 2022filed 7 Jun 2022 | DCOY Decoy TherapeuticsBiotechnology | SEC FORM 4 Bought | $5,04526,553 at $0.19 | filing |
| 20 Jan 2022filed 21 Jan 2022 | DCOY Decoy Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 2 Dec 2020filed 4 Dec 2020 | DCOY Decoy Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 23 Mar 2020filed 25 Mar 2020 | DCOY Decoy Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —6,000 at $0.00 | filing |
| 11 Feb 2020filed 13 Feb 2020 | DCOY Decoy Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code P | $878,700 at $0.01 | filing |
| 11 Feb 2020filed 12 Feb 2020 | DCOY Decoy TherapeuticsBiotechnology | SEC FORM 4 Bought | $10K8,700 at $1.15 | filing |
| 10 Sep 2019filed 12 Sep 2019 | DCOY Decoy Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —3,000 at $0.00 | filing |
| 14 Jun 2018filed 18 Jun 2018 | DCOY Decoy Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —359,696 at $0.00 | filing |
| 17 Jan 2018filed 19 Jan 2018 | DCOY Decoy Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —250,000 at $0.00 | filing |
| 26 Jul 2017filed 27 Jul 2017 | DCOY Decoy Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 26 May 2017filed 30 May 2017 | DCOY Decoy Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —200,000 at $0.00 | filing |
| 22 Mar 2016filed 24 Mar 2016 | RCKT Rocket Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —135,000 at $0.00 | filing |
| 24 Jun 2015filed 26 Jun 2015 | RCKT Rocket Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | $377K75,000 at $5.03 | filing |
News
No headline names them, or the companies they trade most, lately.